glp-1 colorectal cancer risk study november 2025 drugs and prevention Glucagon-like peptide-1 receptor agonists compared

It functions as an endocrine organ, secreting hormones that facilitate obesity and create a positive feedback loop of hormonal disruption

The risk increases with both dose and duration

However, a recent meta-analysis illustrated that clinical use of TZT for 1 year in the management of obesity and glucose control was superior compared to semaglutide, dulaglutide, degludec, and insulin (Dutta et al

Personalized hormone care that evolves with you, with ongoing provider support, flexible treatment options, and transparent pricing from the start

doi: 10.1186/s40168-023-01520-2 100 ZouJChassaingBSinghVPellizzonMRicciMFytheMDet al

We want to enable you to better your well-being and succeed during your health transformation.